You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

May 8, 2020

Atthachai Homhuan Leads Webinar on Thailand’s Medical Device Regulatory Response to COVID-19

Subscribe to Updates

On May 8, 2020, Atthachai Homhuan, manager, regulatory affairs, at Tilleke & Gibbins, was the invited speaker for a Licensing Executives Society (LES) Thailand webinar about the COVID-19 responses of the Thai Food and Drug Administration (FDA) and the Department of International Trade (DIT). He spoke about the ongoing steps the Thai FDA and DIT have taken to encourage the domestic availability of critical products for the fight against COVID-19.

Within the Thai FDA, the Medical Device Control Division has introduced expedited pathways to speed the registration of tools and equipment necessary for preventing the spread of the virus. The DIT’s involvement has centered around the guidance issued by the Central Committee on Prices of Goods and Services, which has put in place export controls to prevent medical device shortages in Thailand due to exports of equipment such as domestically produced masks.

This members-only webinar was held as part of LES Thailand’s efforts to share timely information on intellectual property commercialization, licensing activities, and business-related regulatory affairs. LES Thailand brings together entrepreneurs, legal and professional service providers, and many others with common interests in technology licensing and IP. For more information, please visit the LES Thailand website.

RELATED PROFESSIONAL

Industries

Life Sciences

Practices

Regulatory Affairs

Location

RELATED INSIGHTS​ 

October 12, 2012
On November 22, 2012, the Euromoney Legal Media Group will hold its second annual Asia Women in Business Law Awards at the Renaissance Harbour View Hotel in Hong Kong. Again this year, Tilleke & Gibbins stands amongst a leading group of law firms that will be recognized for their commitment to the advancement of women. The firms will be judged on a range of factors, predominately initiatives for gender diversity, innovation, mentoring, talent management, and female leadership within each firm.
Read More
September 5, 2012
Starting October 1, 2012, overseas pharmaceutical manufacturers that have never before been recorded in the Drug Product Registry of Thailand will need to be accredited by the Thai Food and Drug Administration (FDA) before marketing authorization can be obtained. Otherwise, the FDA will not allow the business operator to submit an Application for Importation of Drug Product Sample, which is a required document for drug product registration.
Read More
September 4, 2012
On September 21, 2012, Tilleke & Gibbins, together with the National Innovation Agency, will host a Thai-language seminar on “Medical Devices: Opportunities & Regulations.” The seminar with consist of three presentations, one of which will be conducted by Rarana Phanudulkitti, a consultant at Tilleke & Gibbins. With her expertise in regulatory affairs, Rarana will deal specifically with registering medical devices in Thailand, with an emphasis on best practices for companies in ensuring a smooth registration process.
Read More